Abstract Details

Title Efficacy and Tolerability of Rotigotine in the Treatment of Patients with Most Severe RLS and Augmentation - A 12 Months Clinical Survey

Topic Sleep

Presentation(s) (-)

Poster/Presentation
Number 057

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jana Godau, MD (Movement Disorders)	No disclosure on file
	No disclosure on file
Pawel Tacik, MD (Mayo Clinic Florida, Department of Neurology)	The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, Anavex Life Sciences Corp. The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, AbbVie Germany, Boston Scientific Medical Technology, Medtronic. Dr. Tacik has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Merz Therapeutics, Ipsen Pharma.
Alessandra Protti	No disclosure on file

��ɫ��